Appendix 2

Tabled documents, Additional information, Answers to questions on notice

Tabled documents

  1. Opening statement tabled by VADM David Johnston, AO, RAN, Vice Chief of the Defence at a public hearing in Canberra on 11 October 2018.
  2. Letter from AVM Tracy Smart to AVM Tindall tabled by AVM Tracy Smart at a public hearing in Canberra on 11 October 2018.
  3. Opening statement tabled by Mrs Naomi Kruizinga at a public hearing in Melbourne on 5 November 2018.
  4. Opening statement tabled by Mr Michael Kruizinga at a public hearing in Melbourne on 5 November 2018.

Additional information

  1. Correspondence from Minister for Veterans' Affairs, The Hon Darren Chester MP, response to Committee Chair, received 18 September 2018.
  2. Clarification of evidence provided on 8 November 2018 from Biocelect Pty Ltd, received 19 November 2018.
  3. Additional information provided by Roche Products, received 19 November 2018.

Answers to questions on notice

  1. Department of Veterans' Affairs, Answers to questions on notice following the Brisbane and Townsville public hearings on 30 and 31 August 2018, received 9 October 2018.
  2. Royal Australian College of General Practitioners, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received 31 October 2018.
  3. Department of Veterans' Affairs, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received 1 November 2018.
  4. Department of Defence, Answers to written questions on notice, received 6 November 2018.
  5. Roche Products Pty Ltd, Answers to questions taken on notice at 8 November 2018 hearing in Canberra, received 19 November 2018.  
  6. Department of Health, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received on 16 November 2018.
  7. GlaxoSmithKline Australia Pty Ltd, Answers to questions taken on notice at 8 November 2018 hearing in Canberra, received 21 November 2018

Navigation: Previous Page | Contents | Next Page

Top